Sponsor
Articles matching:
New Topics in Cardiology
See All >>1 Comparison of alternate day atorvastatin treatment to daily treatment in maintaining LDL-Cholesterol targets in patients with variable coronary risk profile Journal of Cardiovascular Pharmacology, April 2, 2012
2 Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials Lipids in Health and Disease, April 5, 2012 Free full text
3 Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the lunar study) The American Journal of Cardiology, April 17, 2012
4 Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation British Journal of Clinical Pharmacology, April 24, 2012
5 Evidence-based Use of Statins for Primary Prevention of Cardiovascular Disease American Journal of Medicine, April 9, 2012 Evidence Based Medicine
6 Statins as a possible cause of inflammatory and necrotizing myopathies Atherosclerosis, April 23, 2012
7 Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure JAMA, April 12, 2012
8 Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias Pharmacoepidemiology and Drug Safety, April 4, 2012
9 Effects of Celecoxib On Restenosis after Coronary Intervention and Evolution of Atherosclerosis (Mini-COREA) Trial: celecoxib, a double-edged sword for patients with angina European Heart Journal, March 12, 2012
10 Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial Catheterization and Cardiovascular Interventions, April 19, 2012
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor